FDA, USPTO In Middle Of Congressional Tug-Of-War Over Patents And Drug Pricing

 
• By Brenda Sandburg

Senators Hassan and Cassidy contend the lack of coordination between the two agencies may allow patent thickets to grow. Meanwhile, Sen. Tillis is pushing the agency to refute data alleging patents are to blame for high drug prices.

Tug of war
FDA AND USPTO Are Asked To Play Role In Congressional Dispute Over Pharma Patents • Source: Shutterstock

More from Legal & IP

More from Pink Sheet